U.S., Oct. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07880327) titled 'Psyllium Husk in Pediatric IBS' on Oct. 05.
Brief Summary: Children aged 6 to 17 years with IBS will be randomly assigned to either receive psyllium husk supplementation in addition to usual care or receive usual care alone. The study will compare gastrointestinal symptoms, quality of life, and gut microbiota between the two groups.
Study Start Date: Oct. 10
Study Type: INTERVENTIONAL
Condition:
Prebiotic
IBS (Irritable Bowel Syndrome)
Psyllium
Quality of Life (QOL)
Intervention:
DIETARY_SUPPLEMENT: Psyllium Husk
Psyllium husk supplementation administered in addition to conventional therapy. Children aged 6-12 years will rece...